Leonteq Securities’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Leonteq Securities's AXSM Position: Q3 2026 in Review
Leonteq Securities held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 2,616 shares worth $482K. The position accounts for 0.02% of the portfolio, ranked #341.
Leonteq Securities first reported a position in AXSM in Q1 2022 and has held it in 19 quarters since. The position peaked at $640K in Q2 2026. 464 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Leonteq Securities held 2,616 shares of Axsome Therapeutics worth $482K as of Q3 2026.
- Leonteq Securities left its Axsome Therapeutics share count unchanged in Q3 2026.
- Axsome Therapeutics made up 0.02% of Leonteq Securities's portfolio in Q3 2026, its #341 holding.
- Leonteq Securities first reported a position in Axsome Therapeutics in Q1 2022 and has held it in 19 quarters since.
- Leonteq Securities's Axsome Therapeutics position peaked at $640K in Q2 2026.
- 464 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.